Literature DB >> 6978218

B and T cell involvement in anti-acetylcholine receptor antibody formation in myasthenia gravis.

N Shinomiya, J Yata.   

Abstract

The in vitro method of antibody production was applied to ascertain the contribution of B and T cells to the formation of anti-acetylcholine receptor (AChR) antibody. The anti-AChR antibody in the culture supernatant was estimated by radioimmunoassay, and the anti-AChR antibody-forming cells from cultures were detected by autoradiography of the antigen-binding cells. Thymic B cells from myasthenia gravis (MG) patients formed antibody when they were cultured with thymic T cells from MG patients and stimulated with AChR antigen. The antibody formation was more vigorous with thymic B cells, which contained more germinal centres. The antibody was also formed from the B and T cell combination of peripheral blood lymphocytes, although the amount was less than that produced by thymic lymphocytes from MG patients. The antibody produced by lymphocytes from MG patients. The antibody produced by lymphocytes from MG patients was suppressed by the addition of T cells from the culture supernatant of normal individuals, but not by autologous or allogeneic T cells from MG patients. The suppression by T cells from normal individuals was abolished when the cells were treated with mitomycin C. These observations indicated that AChR-specific B cells and helper T cells are active, while the suppressor T cells, which are usually present in normal individuals, are defective in MG patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6978218      PMCID: PMC1536385     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Acetylcholine receptor antibodies in myasthenia gravis.

Authors:  S H Appel; R R Almon; N Levy
Journal:  N Engl J Med       Date:  1975-10-09       Impact factor: 91.245

2.  Detection of anti-acetylcholine receptor factors in serum and thymus from patients with myasthenia gravis.

Authors:  T Mittag; P Kornfeld; A Tormay; C Woo
Journal:  N Engl J Med       Date:  1976-03-25       Impact factor: 91.245

3.  Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis.

Authors:  A Aharonov; O Abramsky; R Tarrab-Hazdai; S Fuchs
Journal:  Lancet       Date:  1975-08-23       Impact factor: 79.321

4.  Lymphocyte subpopulation in neoplastic and non-neoplastic thymus and in blood of patients with Myasthenia gravis.

Authors:  T Shirai; M Miyata; A Nakase; T Itoh
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

5.  Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.

Authors:  J M Lindstrom; M E Seybold; V A Lennon; S Whittingham; D D Duane
Journal:  Neurology       Date:  1976-11       Impact factor: 9.910

6.  Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice.

Authors:  K V Toyka; D B Drachman; D E Griffin; A Pestronk; J A Winkelstein; K H Fishbeck; I Kao
Journal:  N Engl J Med       Date:  1977-01-20       Impact factor: 91.245

Review 7.  Studies on the nature of autoimmunity in myasthenia gravis. Evidence for an immunodeficiency type.

Authors:  J A Simpson; P O Behan; H M Dick
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

8.  An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis.

Authors:  J Lindstrom
Journal:  Clin Immunol Immunopathol       Date:  1977-01

9.  T-cell regulation of antibody responses: demonstration of allotype-specific helper T cells and their specific removal by suppressor T cells.

Authors:  L A Herzenberg; K Okumura; H Cantor; V L Sato; F W Shen; E A Boyse; L A Herzenberg
Journal:  J Exp Med       Date:  1976-08-01       Impact factor: 14.307

10.  Genetic control of specific immune suppression. IV. Responsiveness to the random copolymer L-glutamic acid50-L-tyrosine50 induced in BALB/c mice by cyclophosphamide.

Authors:  P Debré; C Waltenbaugh; M E Dorf; B Benacerraf
Journal:  J Exp Med       Date:  1976-07-01       Impact factor: 14.307

View more
  2 in total

1.  Immediate effects of intravenous IgG administration on peripheral blood B and T cells and polymorphonuclear cells in patients with myasthenia gravis.

Authors:  L Cook; J F Howard; J D Folds
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

2.  In vitro anti-acetylcholine receptor antibody synthesis by myasthenia gravis patient lymphocytes: correlations with thymic histology and thymic epithelial-cell interactions.

Authors:  D Safar; S Berrih-Aknin; E Morel
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.